Department of Emergency, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2632-2639. doi: 10.26355/eurrev_202003_20532.
Sepsis is an important cause of acute kidney injury (AKI), seriously jeopardizing the health of patients. This paper's aim was to investigate whether microRNA-133a had a protective effect on sepsis-induced kidney injury.
We established a kidney injury model with lipopolysaccharide (LPS) and divided TCMK-1 cells into 4 groups: control group (con); LPS treatment group; LPS + negative control (NC) treatment group; LPS + miR-133a mimic (mim) group. The expressions of miR-133a, TNF-α mRNA, IL-6 mRNA, Bax mRNA, Bcl-2 mRNA, BNIP3L mRNA, IκKα Mrna and IκB-α mRNA were detected by PCR. Western blot was used to detect the protein expression of TNF-α, IL-6, Bax, Bcl-2, BNIP3L, IκKα and IκB-α. Cell viability was measured by cell counting kit-8 (CCK-8). Flow cytometry was utilized to detect apoptosis rate. IL-1β immunofluorescence and terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) staining were used to observe the inflammation and apoptosis in TCMK-1 cells.
The miR-133a expression was decreased in TCMK-1 cells treated with LPS. In the LPS treatment group, the expression of TNF-α, IL-6, Bax, BNIP3L and IκKα increased, and the expression of Bcl-2 and IκB-α decreased. When overexpressing miR-133a, the protein and mRNA expression of TNF-α, IL-6, Bax, BNIP3L and IκKα decreased markedly, while the expression of Bcl-2 and IκB-α increased markedly. Compared with the LPS-treated group, the apoptotic rate, the number of TUNEL-positive cells, and the immunofluorescence intensity of IL-1β in LPS+mim group were greatly decreased.
The miR-133a expression was decreased in TCMK-1 cells treated by LPS and miR-133a can inhibit inflammation and apoptosis of TCMK-1 cells induced by LPS by targeting BNIP3L via inhibiting NF-κB pathway.
脓毒症是急性肾损伤(AKI)的重要原因,严重威胁患者健康。本文旨在探讨 microRNA-133a 是否对脓毒症诱导的肾损伤具有保护作用。
我们用脂多糖(LPS)建立了肾损伤模型,并将 TCMK-1 细胞分为 4 组:对照组(con);LPS 处理组;LPS+阴性对照(NC)处理组;LPS+miR-133a 模拟物(mim)组。通过 PCR 检测 miR-133a、TNF-α mRNA、IL-6 mRNA、Bax mRNA、Bcl-2 mRNA、BNIP3L mRNA、IκKα Mrna 和 IκB-α mRNA 的表达。通过 Western blot 检测 TNF-α、IL-6、Bax、Bcl-2、BNIP3L、IκKα 和 IκB-α 的蛋白表达。用细胞计数试剂盒-8(CCK-8)检测细胞活力。通过流式细胞术检测细胞凋亡率。用 IL-1β 免疫荧光和末端脱氧核苷酸转移酶(TdT)介导的 dUTP 缺口末端标记(TUNEL)染色观察 TCMK-1 细胞的炎症和凋亡情况。
LPS 处理后 TCMK-1 细胞中 miR-133a 的表达降低。在 LPS 处理组中,TNF-α、IL-6、Bax、BNIP3L 和 IκKα 的表达增加,而 Bcl-2 和 IκB-α 的表达减少。当过表达 miR-133a 时,TNF-α、IL-6、Bax、BNIP3L 和 IκKα 的蛋白和 mRNA 表达显著降低,而 Bcl-2 和 IκB-α 的表达显著增加。与 LPS 处理组相比,LPS+mim 组的细胞凋亡率、TUNEL 阳性细胞数和 IL-1β 的免疫荧光强度均显著降低。
LPS 处理的 TCMK-1 细胞中 miR-133a 的表达降低,miR-133a 可通过靶向 BNIP3L 抑制 NF-κB 通路抑制 LPS 诱导的 TCMK-1 细胞的炎症和凋亡。